RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of APLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Apellis Pharmaceuticals Inc. stock upgraded to Hold/Accumulate.
(Updated on Mar 28, 2024)

Hold candidate since Mar 28, 2024 PDF

The Apellis Pharmaceuticals Inc. stock price gained 0.496% on the last trading day (Thursday, 28th Mar 2024), rising from $58.49 to $58.78. During the last trading day the stock fluctuated 3.76% from a day low at $56.82 to a day high of $58.96. The price has risen in 6 of the last 10 days and is up by 4.07% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 195 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $71.61 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.91% during the next 3 months and, with a 90% probability hold a price between $48.88 and $58.14 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

APLS Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, March 22, 2024, and so far it has risen 6.12%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Apellis Pharmaceuticals Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $62.59. On a fall, the stock will find some support from the short-term average at $57.05. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Apellis Pharmaceuticals Inc. stock

Apellis Pharmaceuticals Inc. finds support from accumulated volume at $58.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.14 between high and low, or 3.76%. For the last week, the stock has had daily average volatility of 3.69%.

Our recommended stop-loss: $56.29 (-4.24%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (APLS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Apellis Pharmaceuticals Inc. to open at $58.19, and during the day (based on 14 day Average True Range), to move between $56.18 and $61.38, which gives a possible trading interval of +/-$2.60 (+/-4.43%) up or down from last closing price. If Apellis Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 8.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $58.50 (0.48%) than the resistance at $68.35 (16.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Apellis Pharmaceuticals Inc. stock A Buy?

Apellis Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.679 Hold/Accumulate Upgraded

Predicted Opening Price for Apellis Pharmaceuticals Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$58.19 ( 1.01%) $58.78

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for APLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 60.32 2.62 %
R2 59.50 1.23 %
R1 59.00 0.375 %
Current price: 58.78
Support S1 57.37 -2.40 %
S2 56.87 -3.26 %
S3 56.05 -4.64 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 72.47 23.29 %
R2 69.35 17.98 %
R1 68.35 16.28 %
Current price 58.78
Support S1 58.50 -0.476%
S2 56.48 -3.91%
S3 55.52 -5.55%

FAQ

What is the symbol for Apellis Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Apellis Pharmaceuticals Inc. is APLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Apellis Pharmaceuticals Inc. Stock?
Apellis Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Apellis Pharmaceuticals Inc. Stock?
Apellis Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Apellis Pharmaceuticals Inc. Stock.

What's the current price of Apellis Pharmaceuticals Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Apellis Pharmaceuticals Inc. (APLS) share was $58.78.

What is the 52-week high and low for Apellis Pharmaceuticals Inc. Stock?
The 52-week high for Apellis Pharmaceuticals Inc. Stock is $94.75 and the 52-week low is $19.83.

What is the market capitalization of Apellis Pharmaceuticals Inc. Stock?
As of the 2024-03-28, the market capitalization of Apellis Pharmaceuticals Inc. is 7.053B.

When is the next earnings date for Apellis Pharmaceuticals Inc.?
The upcoming earnings date for Apellis Pharmaceuticals Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals. Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy (GA) in age-related macular degeneration and paroxysmal nocturnal ... APLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT